Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Jichi Medical University has 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 4 distinct examiners, which means that no two pending matters are being reviewed by the same person. This spread suggests a diverse range of technical subject matter within the portfolio.
The portfolio's current activity is also spread across 4 distinct art units. This indicates that the 4 pending office actions are being handled by four different specialized groups at the patent office. SHEN, WU CHENG WINSTON is the busiest examiner, responsible for 1 busiest examiner pending action.
With 4 distinct examiners each handling 1 of the 4 pending actions, the prosecution progress is decentralized. This prevents any single examiner from having a disproportionate impact on the overall portfolio timeline. Practitioners must manage four separate examiner relationships to resolve the current Biotechnology & Pharmaceuticals actions.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (25%) |
| §103 only | 1 (25%) |
| Multi-statute (no §101) | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHEN, WU CHENG WINSTON | 1 | 23.4% | +25.2% |
| XU, QING | 1 | 50.9% | +55.2% |
| MARLEN, TAMMIE K | 1 | 75.3% | +20.8% |
| GRABER, JAMES J | 1 | 46.5% | +57.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17176390 | PHYSIOLOGICAL INFORMATION PROCESSING APPARATUS, PHYSIOLOGICAL INFORMATION PROCESSING METHDO AND STORAGE MEDIUM | MARLEN, TAMMIE K | 12d |
| 17914323 | TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT | SHEN, WU CHENG WINSTON | — |
| 17042819 | GENOME EDITING METHOD, COMPOSITION, CELL, CELL PREPARATION, AND METHOD FOR PRODUCING CELL PREPARATION | GRABER, JAMES J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17176390 | PHYSIOLOGICAL INFORMATION PROCESSING APPARATUS, PHYSIOLOGICAL INFORMATION PROCESSING METHDO AND STORAGE MEDIUM | MARLEN, TAMMIE K | 12d |
| 17782531 | PREPARATION OF ADIPOSE TISSUE-DERIVED CELL POPULATION | XU, QING | 21d |
| 17914323 | TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT | SHEN, WU CHENG WINSTON | — |
| 17042819 | GENOME EDITING METHOD, COMPOSITION, CELL, CELL PREPARATION, AND METHOD FOR PRODUCING CELL PREPARATION | GRABER, JAMES J | — |
| Art Unit | Apps |
|---|---|
| 1682 | 1 |
| 1656 | 1 |
| 3796 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17914323 | TEMPORARY TREATMENT MEDIUM, TREATMENT KIT, EMBRYOGENESIS ARREST INHIBITOR, EMBRYOGENESIS ARREST INHIBITORY METHOD, DEVELOPMENTAL ENGINEERING PRODUCT PREPARATION METHOD, TRANSPLANTATION METHOD, THERAPEUTIC METHOD, AND DEVELOPMENTAL ENGINEERING PRODUCT | SHEN, WU CHENG WINSTON | 1682 | §102§103§112 | Non-Final OA | — | Pending | Sep 24, 2022 |
| 17782531 | PREPARATION OF ADIPOSE TISSUE-DERIVED CELL POPULATION | XU, QING | 1656 | §103 | Non-Final OA | 21d | Pending | Jun 03, 2022 |
| 17176390 | PHYSIOLOGICAL INFORMATION PROCESSING APPARATUS, PHYSIOLOGICAL INFORMATION PROCESSING METHDO AND STORAGE MEDIUM | MARLEN, TAMMIE K | 3796 | §101§102§103 | Non-Final OA | 12d | Pending | Feb 16, 2021 |
| 17042819 | GENOME EDITING METHOD, COMPOSITION, CELL, CELL PREPARATION, AND METHOD FOR PRODUCING CELL PREPARATION | GRABER, JAMES J | 1631 | §102§103 | Non-Final OA | — | Pending | Sep 28, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJichi Medical University has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Wu Cheng Winston Shen has the most, with 1 of Jichi Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
